retatrutide mechanism triple agonist glp-1 gip glucagon retatrutide Retatrutide: The "Triple G" Peptide That Could Rival Bariatric Surgery (And Why You Shouldn't Wait) retatrutide triple agonist glp-1 gip

Semaglutide (Ozempic) and tirzepatide (Mounjaro) are FDA-approved only for type 2 diabetes management, not for weight loss

Having hypothyroidism does not make these medications less effective or more dangerous when thyroid hormone levels are appropriately managed with levothyroxine

doi: 10.1016/j.tem.2016.10.001 30 DuringMJCaoLZuzgaDSFrancisJSFitzsimonsHLJiaoXet al

Moreover, each study used different time frames for follow-up, which adds to the heterogeneity of our results and makes it impossible to assess the long-term outcomes

The pressures of maintaining a polished and flawless appearance in social and professional settings have made these treatments increasingly popular